Immunoglobulin (Ig) replacement therapy (IgRT) consists of the administration of low-doses human polyclonal Igs for the treatment of primary and secondary hypogammaglobulinemia, characterized by low serum levels of immunoglobulins that is associated with recurrent infections and immune dysfunction. The gene discussed is CUBN; the disease is immune system disorder.